Hg Capital, a private equity firm targeting technology buyouts primarily in Europe and the US, agreed to acquire the remaining stake in Evaluate Group, a London-headquartered provider of commercial intelligence to the global life sciences industry. The acquisition is structured on behalf of Hg Mercury 2 Fund. Previously, Hg Mercury 1 acquired a minority stake in the target. Financial terms were not disclosed.